UK life sciences venture capital funding lags behind
In 2024, life sciences was the only tech sector analysed where the UK had not improved its global share of…
In 2024, life sciences was the only tech sector analysed where the UK had not improved its global share of…
Amidst a wave of regulatory changes in the European Union (EU) that are underway, the new EU Health Data Space…
In recent years, major progress has been made in the development of gene therapies for rare diseases. However, research for…
Amid a wave of healthcare regulatory changes in the EU, an update on health technology assessment (HTA) regulation is set…
Neumora Therapeutics saw a drop of more than 80% in its share price following the announcement of a Phase III…
As countries in the Northern hemisphere deal with the flu season, experts say regulation surrounding flu vaccines could be due…
Research activity in the human immunodeficiency viruses space (HIV) is pivoting towards pre-exposure prophylaxis (PrEP) therapies as vaccine failures rack…
As the US enters a new political era, experts predict that the pharmaceutical and clinical trials industry will have to…
As biosimilars continue to arrive on the psoriasis scene, wider measures to influence drug access and emerging treatment choices in…
Geopolitical events and economic fluctuations have impacted the pharmaceutical industry, inducing a wave of layoffs that have hit both pharma…